While combination chemo-immunotherapy has shown considerable potential in treating triple-negative breast cancer (TNBC), the inhibitory effects of the tumor microenvironment (TME) on cancer immunotherapy remain a significant challenge. Previous studies have demonstrated that EphB4 contributes ...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.